TORONTO, ON — LifeLabs is pleased to share the launch of SignateraTM, a highly sensitive, personalized molecular residual disease assay (MRD) test developed by Natera for treatment monitoring and molecular residual disease… Read More
Clinical trial will be the first to test whole Psilocybe mushrooms for safety and efficacy in a clinical setting; study is expected to provide important data to support increased access to… Read More
The first randomized, placebo-controlled, single-blind clinical study of Steriwave™ nasal photodisinfection in 75 predominantly vaccinated COVID-19 patients has been published. VANCOUVER, BC — (BUSINESS WIRE) — The study, published in… Read More
VANCOUVER, BC, MONTREAL, QC, and TORONTO, ON — adMare BioInnovations is pleased to announce the launch of the adMare Tx Accelerator that will support the most promising ventures across Canada… Read More
SANTA MONICA & REDWOOD CITY, CA — (BUSINESS WIRE) — Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX), today announced the closing of the companies’ previously announced global strategic… Read More
